Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001613780-25-000016
Filing Date
2025-07-29
Accepted
2025-07-29 16:01:25
Documents
78
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dbvt-20250630.htm   iXBRL 10-Q 1009672
7 EX-3.1 exhibit31-bylawsxdbv10xq_u.htm EX-3.1 91135
8 EX-31.1 exhibit311-dbv_10xqxq2x2025.htm EX-31.1 10148
9 EX-31.2 exhibit312-dbv_10xqxq2x2025.htm EX-31.2 10177
10 EX-32.1 exhibit321-dbv_10xqxq2x2025.htm EX-32.1 6331
  Complete submission text file 0001613780-25-000016.txt   5837047

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dbvt-20250630.xsd EX-101.SCH 56105
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dbvt-20250630_cal.xml EX-101.CAL 69312
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dbvt-20250630_def.xml EX-101.DEF 188517
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dbvt-20250630_lab.xml EX-101.LAB 542844
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dbvt-20250630_pre.xml EX-101.PRE 371733
81 EXTRACTED XBRL INSTANCE DOCUMENT dbvt-20250630_htm.xml XML 718183
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36697 | Film No.: 251161713
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)